订阅小程序
旧版功能

1105P Outcomes of Real-World (RW) Patients (pts) with Advanced NSCLC (ansclc) and High Programmed Cell Death-Ligand 1 (PD-L1) Expression Receiving First Line (1L) Immune Checkpoint Inhibitor (ICI) Therapy

M. L. Hsu,W. Ge,N. Wu,R. Quek, J. Liu, J. J. Jalbert,P. Rietschel,J. Feliciano,J. Harnett

ANNALS OF ONCOLOGY（2022）

引用 0|浏览29
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要